Damla Yasemin YENLİÇ KAYA

Dr. Damla Yasemin YENLİÇ KAYA

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in Bagcilar Medical Bulletin
Verified
Journal Article
Closed access
DKDamla Yasemin YENLİÇ KAYA
Damla Yasemin YENLİÇ KAYA
YKYücel Kaya
Yücel Kaya
VMVeli Mihmanlı
Veli Mihmanlı
MTMurat ibrahim Toplu
Murat ibrahim Toplu
YÖYağmur Ölmez
Yağmur Ölmez

13 February 2025 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
PDF file
AJAytaj Jafarzade
Aytaj Jafarzade
VMVeli Mi̇hManli
Veli Mi̇hManli
YAYavuz
Yavuz
MAMurat Akbaş
Murat Akbaş
GTGürcan Türkyilmaz
Gürcan Türkyilmaz
MMMuhittin Tamer Mungan
Muhittin Tamer Mungan
Objective The study aimed to determine the level of anemia in pregnant women in the first trimester and in the preconception period by conducting nationwide research. Methods The study was designed as retrospective, cross-sectional, and multicenter research. A total of 17 centers from 13 provinces were included in the study. The study was conducted […] Abstract Objective The study aimed to determine the level of anemia in pregnant women in the first trimester and in the preconception period by conducting nationwide research. Methods The study was designed as retrospective, cross-sectional, and multicenter research. A total of 17 centers from 13 provinces were included in the study. The study was conducted […]

1 March 2023 in Bagcilar Medical Bulletin
Verified
Journal Article
Closed access
YÖYağmur Özkan
Yağmur Özkan
SGSimten Genç
Simten Genç
YKYücel Kaya
Yücel Kaya
DKDamla Yasemin YENLİÇ KAYA
Damla Yasemin YENLİÇ KAYA
VMVeli Mihmanlı
Veli Mihmanlı

22 September 2022 in Bagcilar Medical Bulletin
Verified
Journal Article
Closed access
YKYücel Kaya
Yücel Kaya
NTNedim Tokgözoğlu
Nedim Tokgözoğlu
GDGökhan Demirayak
Gökhan Demirayak
VMVeli Mihmanlı
Veli Mihmanlı
DKDamla Yasemin YENLİÇ KAYA
Damla Yasemin YENLİÇ KAYA
HUHamit Caner Uzun
Hamit Caner Uzun

19 September 2026 in Medicina
Verified
Journal Article
Open access
PDF file
YKYücel Kaya
Yücel Kaya
KBKübra Kurt Bilirer
Kübra Kurt Bilirer
ABAybekcan Batman
Aybekcan Batman
BÇBURCU ÇIÇEK
BURCU ÇIÇEK
İYİlteriş Yaman
İlteriş Yaman
GPGülseren Polat
Gülseren Polat
Background and Objectives: To evaluate the association between the newly defined cerebroplacental–renal ratio (CPRR) and adverse perinatal outcome (APO) in pregnancy-induced hypertension (PIH), and to compare its discriminative performance with the cerebroplacental ratio (CPR) and cerebroplacental–uterine ratio (CPUR). Materials and Methods: This prospective, single-center cohort study included 105 women with PIH (preeclampsia, n = 63; gestational hypertension, n = 42). Doppler assessment was performed at ≥34 + 0 weeks and within 7 days before delivery. CPR was calculated as middle cerebral artery pulsatility index (PI)/umbilical artery PI, CPUR as CPR/mean uterine artery PI, and CPRR as CPR/right renal artery PI. APO was defined by the presence of any of the following: non-reassuring fetal status, a 5 min Apgar score <7, neonatal intensive care unit admission, or neonatal death. Receiver operating characteristic analysis and multivariable logistic regression adjusted for gestational age at ultrasound assessment and diagnosis group were performed. Results: APO occurred in 37 pregnancies (35.2%). CPUR and CPRR were significantly lower in the APO group, whereas CPR did not differ significantly. CPRR showed a higher apparent AUC for APO than CPR and CPUR (AUC 0.786, 95% CI 0.698–0.875), with significantly higher AUCs on pairwise DeLong comparisons. After adjustment, CPRR was the only Doppler index independently associated with APO (adjusted OR 1.423 per 0.1-unit decrease; 95% CI 1.162–1.743; p = 0.001). Conclusions: CPRR was independently associated with APO in PIH and showed higher discriminative performance than CPR and CPUR; however, these findings require validation in independent, multicenter studies before clinical application.